Current Environment: Production

Timothy Buie | Education

Medical School

University of Missouri at Kansas City

1984, Kansas City, MO

Residency

Bridgeport Hospital

1988, Bridgeport, CT

Fellowship

Yale Medical School

1990, New Haven, CT

Timothy Buie | Certifications

  • American Board of Pediatrics (Gastroenterology)

Timothy Buie | Professional History

I am a general pediatric gastroenterologist focused on the care of children with autism and developmental problems. These problems include similar problems seen in general pediatric GI care but recognizing these problems in children with developmental problems is often difficult. This has been my focus.

Timothy Buie | Media

Managing Medical Issues

Managing GI Medical Issues in Autism

Managing Medical Issues

Avoidant Restrictive Food Disorders (ARFID) in Children with Autism

Managing Medical Issues

Behaviors in Autism and GI Issues

Managing Medical Issues

Communicating Pain and Illness: A Challenge for Children with Autism

Managing Medical Issues

Treating Children with Autism and GI Problems

Managing Medical Issues

Looking for Answers: The Microbiome in Autism

Timothy Buie | Publications

  1. Considerations for treating autistic individuals in gastroenterology clinics. Lancet Gastroenterol Hepatol. 2024 Aug; 9(8):684-686. View Considerations for treating autistic individuals in gastroenterology clinics. Abstract

  2. Comparing Gastrointestinal Endoscopy Findings in Children with Autism, Developmental Delay, or Typical Development. J Pediatr. 2024 Jan; 264:113737. View Comparing Gastrointestinal Endoscopy Findings in Children with Autism, Developmental Delay, or Typical Development. Abstract

  3. Evaluation of Gastroesophageal Reflux Disease in Children on the Autism Spectrum: A Study Evaluating the Tolerance and Utility of the BRAVO Wireless pH Monitoring. J Pediatr Gastroenterol Nutr. 2022 10 01; 75(4):450-454. View Evaluation of Gastroesophageal Reflux Disease in Children on the Autism Spectrum: A Study Evaluating the Tolerance and Utility of the BRAVO Wireless pH Monitoring. Abstract

  4. Characteristics of the autism spectrum disorder gastrointestinal and related behaviors inventory in children. Autism Res. 2022 06; 15(6):1142-1155. View Characteristics of the autism spectrum disorder gastrointestinal and related behaviors inventory in children. Abstract

  5. Development of a Brief Parent-Report Screen for Common Gastrointestinal Disorders in Autism Spectrum Disorder. J Autism Dev Disord. 2019 Jan; 49(1):349-362. View Development of a Brief Parent-Report Screen for Common Gastrointestinal Disorders in Autism Spectrum Disorder. Abstract

  6. Age-Dependent Changes in the Propofol-Induced Electroencephalogram in Children With Autism Spectrum Disorder. Front Syst Neurosci. 2018; 12:23. View Age-Dependent Changes in the Propofol-Induced Electroencephalogram in Children With Autism Spectrum Disorder. Abstract

  7. Mitochondrial dysfunction in the gastrointestinal mucosa of children with autism: A blinded case-control study. PLoS One. 2017; 12(10):e0186377. View Mitochondrial dysfunction in the gastrointestinal mucosa of children with autism: A blinded case-control study. Abstract

  8. Analysis of the Duodenal Microbiome in Autistic Individuals: Association With Carbohydrate Digestion. J Pediatr Gastroenterol Nutr. 2017 05; 64(5):e110-e116. View Analysis of the Duodenal Microbiome in Autistic Individuals: Association With Carbohydrate Digestion. Abstract

  9. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol Autism. 2016; 7:49. View Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Abstract

  10. Evaluation of Intestinal Function in Children With Autism and Gastrointestinal Symptoms. J Pediatr Gastroenterol Nutr. 2016 05; 62(5):687-91. View Evaluation of Intestinal Function in Children With Autism and Gastrointestinal Symptoms. Abstract

  11. Early Identification and Interventions for Autism Spectrum Disorder: Executive Summary. Pediatrics. 2015 Oct; 136 Suppl 1:S1-9. View Early Identification and Interventions for Autism Spectrum Disorder: Executive Summary. Abstract

  12. Early Identification of Autism Spectrum Disorder: Recommendations for Practice and Research. Pediatrics. 2015 Oct; 136 Suppl 1:S10-40. View Early Identification of Autism Spectrum Disorder: Recommendations for Practice and Research. Abstract

  13. Early Screening of Autism Spectrum Disorder: Recommendations for Practice and Research. Pediatrics. 2015 Oct; 136 Suppl 1:S41-59. View Early Screening of Autism Spectrum Disorder: Recommendations for Practice and Research. Abstract

  14. Early Intervention for Children With Autism Spectrum Disorder Under 3 Years of Age: Recommendations for Practice and Research. Pediatrics. 2015 Oct; 136 Suppl 1:S60-81. View Early Intervention for Children With Autism Spectrum Disorder Under 3 Years of Age: Recommendations for Practice and Research. Abstract

  15. Potential Etiologic Factors of Microbiome Disruption in Autism. Clin Ther. 2015 May 01; 37(5):976-83. View Potential Etiologic Factors of Microbiome Disruption in Autism. Abstract

  16. The relationship of autism and gluten. Clin Ther. 2013 May; 35(5):578-83. View The relationship of autism and gluten. Abstract

  17. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One. 2011; 6(9):e24585. View Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. Abstract

  18. Intestinal disaccharidase activity in patients with autism: effect of age, gender, and intestinal inflammation. Autism. 2011 May; 15(3):285-94. View Intestinal disaccharidase activity in patients with autism: effect of age, gender, and intestinal inflammation. Abstract

  19. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010 Jan; 125 Suppl 1:S1-18. View Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Abstract

  20. Recommendations for evaluation and treatment of common gastrointestinal problems in children with ASDs. Pediatrics. 2010 Jan; 125 Suppl 1:S19-29. View Recommendations for evaluation and treatment of common gastrointestinal problems in children with ASDs. Abstract

  21. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics. 2009 Mar; 123(3):1018-24. View Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Abstract

  22. Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PLoS One. 2008 Sep 04; 3(9):e3140. View Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. Abstract

  23. Glucocorticoid responsiveness in developing human intestine: possible role in prevention of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2005 Jan; 288(1):G85-92. View Glucocorticoid responsiveness in developing human intestine: possible role in prevention of necrotizing enterocolitis. Abstract

  24. Abnormalities in gastrointestinal motility are associated with diseases of oxidative phosphorylation in children. Am J Gastroenterol. 2003 Apr; 98(4):871-7. View Abnormalities in gastrointestinal motility are associated with diseases of oxidative phosphorylation in children. Abstract

  25. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr. 1995 Aug; 21(2):224-6. View Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. Abstract

  26. Intestinal motility and jejunal feeding in children with chronic intestinal pseudo-obstruction. Gastroenterology. 1995 May; 108(5):1379-85. View Intestinal motility and jejunal feeding in children with chronic intestinal pseudo-obstruction. Abstract

  27. Immunoglobulin studies in children with inflammatory bowel disease. Ann Allergy. 1994 Jun; 72(6):525-7. View Immunoglobulin studies in children with inflammatory bowel disease. Abstract

  28. Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient. Am J Med Genet. 1994 May 01; 50(4):347-52. View Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient. Abstract

  29. Tetracycline-induced esophagitis in adolescent patients. J Pediatr. 1992 Jan; 120(1):144-5. View Tetracycline-induced esophagitis in adolescent patients. Abstract

It became clear that children with developmental problems were often suffering physical distress that they were unable to verbalize and problem behaviors often seen in these children were, at times, set off by medical issues. I have focused on the care of these children for over 20 years as well as expanding education about these issues in the medical community.

BESbswy
BESbswy